 | Your browser does not display parts of our website correctly. We use the latest technology available to provide you with a high quality experience; please upgrade your browser to its latest version to view the contents properly: |
Stockwinners Market Radar for June 12, 2022 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service |
| APLS | Hot Stocks12:04 EDT Apellis' pegcetacoplan granted FDA orphan designation - Apellis Pharmaceuticals' pegcetacoplan was granted FDA orphan designation as a treatment of immune complex-membranoproliferative glomerulonephritis, according to a post to the agency's website. Reference Link
|
